Vitamin C deployed in big doses to help treat coronavirus patients
Hospitals in the United States and China administer the supplement as part of a therapy for people with Covid-19.
Vitamin C is often suggested as a dietary supplement for people who have caught a cold, but is not considered a cure for diseases like influenza.
A similar treatment is also being tested in Wuhan, the central Chinese city where the coronavirus was first detected.
Professor Liu Shi of Wuhan Union Hospital, said the medical centre, which has a large number of Covid-19 patients with severe symptoms, had also tried the therapy.
“It was also administered to the patients intravenously, along with other drugs, because they are all seriously ill,” she said.
“We still don’t know whether this helps [their] recovery – this needs a lot of research,” she said, adding that unlike vitamins A and D, Vitamin C is not toxic even if consumed in high doses because it is water soluble and therefore can be excreted easily.
Professor Yang Jinkui, from Beijing Tongren Hospital, said there was no scientific evidence to support the use of Vitamin C and any suggestion that it could be an effective cure was “completely groundless”.
“In my understanding, it may be serving as a placebo as there is no special drug for this new disease yet. Sometimes it is deception with good intentions,” Yang said.
“[People] in different countries may have different fixations with some particular therapies, just like we [Chinese people] prefer herbal medicine.”
Wang Xiaogang, a doctor at Beijing Hospital, who has treated seriously ill coronavirus patients in Wuhan, agreed that there was no clinical evidence to prove that Vitamin C really helped.
“This is meaningless,” Wang said.
Scientific studies to date only suggested that Vitamin C might have an effect in the treatment of cancer, cardiovascular disease, age-related macular degeneration and the common cold, according to the NIH.
2026-10-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Dafeng Haijianuo’s RMB 246 Million Technical Revamp Project Takes Shape, with Multiple Production Lines for Vitamin K1, Folic Acid, and Others Under Construction
-
Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab
-
Personalized supplements startup VitaminLab raises series A financing
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
Vitamin Market Analysis
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
Are More 'Vitamins' in The Feed the Better?
-
Vitamin Market Analysis
-
What do we need to pay attention to in order to regulate qi and blood with diet?
-
Analysis of Functional Food for Relieving Visual Fatigue And Its Functional Components
Recommend Reading
-
Kraton Announces Strategic Plan to Streamline Polymer Operations in Berre, France
-
Middle East Crude Exports Rebound Sharply in September as Saudi Arabia Returns to Market at 5.4 Million bpd
-
UAE Breaks Ground on World’s First Gigascale Round-the-Clock Renewable Energy Project, Setting a New Global Standard For Clean Energy
-
Wacker Under Global Cost Pressure: Dual-Track Restructuring Through Layoffs, Consolidation, and Strategic Repositioning
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
Vendor Shipment Surge Halts Mid-October PC Price Increase
-
Change Rate Remains Positive, This Round of Refined Oil Retail Prices in China Is About to Increase
-
Premium Global Chemical Sourcing Requests (3-7 Nov 2025)
-
Acetic Acid Market Continues to Decline in China
-
Recent Stable and Slight Increase in Formic Acid Prices in China